The Biopharmaceutics Classification System (BCS) is a system to differentiate drugs on the basis of their solubility and permeability. This system restricts the prediction using the parameters solubility and intestinal permeability. The solubility classification is based on a United States Pharmacopoeia (USP) aperture. The intestinal permeability classification is based on a comparison to the intravenous injection. All those factors are highly important because 85% of the most sold drugs in the

United States The United States of America (USA), also known as the United States (U.S.) or America, is a country primarily located in North America. It is a federal republic of 50 U.S. state, states and a federal capital district, Washington, D.C. The 48 ...

and

Europe Europe is a continent located entirely in the Northern Hemisphere and mostly in the Eastern Hemisphere. It is bordered by the Arctic Ocean to the north, the Atlantic Ocean to the west, the Mediterranean Sea to the south, and Asia to the east ...

are orally administered.

Classes

According to the Biopharmaceutics Classification System (BCS) drug substances are classified to four classes upon their solubility and permeability: * Class I – high permeability, high solubility ** Example: metoprolol, paracetamol ** Those compounds are well absorbed and their absorption rate is usually higher than excretion. * Class II – high permeability, low solubility ** Example: glibenclamide, bicalutamide, ezetimibe, aceclofenac ** The bioavailability of those products is limited by their solvation rate. A correlation between the '' in vivo'' bioavailability and the '' in vitro'' solvation can be found. * Class III – low permeability, high solubility ** Example: cimetidine ** The absorption is limited by the permeation rate but the drug is solvated very fast. If the formulation does not change the permeability or gastro-intestinal duration time, then class I criteria can be applied. * Class IV – low permeability, low solubility ** Example: bifonazole ** Those compounds have a poor bioavailability. Usually they are not well absorbed over the intestinal mucosa and a high variability is expected.

Definitions

The drugs are classified in BCS on the basis of solubility and permeability. Solubility class boundaries are based on the highest dose strength of an immediate release product. A drug is considered highly soluble when the highest dose strength is soluble in 250 ml or less of aqueous media over the pH range of 1 to 6.8. The volume estimate of 250 ml is derived from typical bioequivalence study protocols that prescribe administration of a drug product to fasting human volunteers with a glass of water. Permeability class boundaries are based indirectly on the extent of absorption of a drug substance in humans and directly on the measurement of rates of mass transfer across human intestinal membrane. Alternatively non-human systems capable of predicting drug absorption in humans can be used (such as in-vitro culture methods). A drug substance is considered highly permeable when the extent of absorption in humans is determined to be 85% or more of the administered dose based on a mass-balance determination or in comparison to an intravenous dose.

References

External links

BCS guidance
of the U.S. Food and Drug Administration Pharmacological classification systems Pharmacy in the United States

Classes

Definitions

See also

References

Further reading

External links